Product Description: Brodimoprim (Ro 10-5970), a trimethoprim analogue, is an orally active dihydrofolate reductase inhibitor. Brodimoprim is highly active against a broad spectrum of gram-negative and gram-positive bacteria[1].
Applications: COVID-19-immunoregulation
Formula: C13H15BrN4O2
References: [1]Weidekamm E. Pharmacokinetics of brodimoprim. J Chemother. 1993;5(6):475-479./[2]Marchese A, et al. Brodimoprim: effects of subminimal inhibitory concentrations on virulence traits of respiratory and urinary tract pathogens, and on plasmid transfer and stability. J Chemother. 1996;8(3):171-177.
CAS Number: 56518-41-3
Molecular Weight: 339.19
Compound Purity: 99.36
Research Area: Infection
Solubility: DMSO : 33.33 mg/mL (ultrasonic)
Target: Bacterial